Composition comprising a thromboxane receptor antagonist and a thromboxane synthase inhibitor combination and a COX-2 inhibitor

摘要

The invention relates to a pharmaceutical composition comprising a combined thromboxane receptor antagonist and thromboxane synthase inhibitor and a COX-2 inhibitor. In addition a method of treating cyclooxygenase dependent disorders, including inflammation, pain and/or rheumatic diseases, and/or neoplasia is described.